Targeted Medical Pharma Introduces Medical Food PERCURA™ for Dietary Management of Peripheral Neurop
Targeted Medical Pharma Introduces Medical Food PERCURA™for Dietary Management of Peripheral Neuropathy
Data Shows New Oral Formulation Reduced Symptoms of Pain and Numbness
LOS ANGELES--(BUSINESS WIRE)-- Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies, today reported preliminary data indicating that its new amino acid-based oral formulation PERCURA™ reduced symptoms of pain and numbness related to peripheral neuropathy in an open-label pilot study.
"Preliminary study results show medical food PERCURA™ was able to reduce symptoms found in subjects suffering from peripheral neuropathy related to diabetes," said William Shell, M.D., CEO and chief scientific officer of Targeted Medical Pharma, Inc. "In 30 percent of the 20 million people suffering from peripheral neuropathy, diabetes is the cause. Our medical foods treat the nutritional deficiencies found in chronic disease such as diabetes by providing the necessary amino acids to improve clinical outcomes without the negative side effects usually associated with pharmaceutical drugs."
The medical food PERCURA™ reduced symptoms of numbness in subjects an average of 57 percent, after the first 30 days of treatment. The pilot also reported an average 56 percent reduction in pain among subjects related to peripheral neuropathy after 30 days of treatment. All subjects are expected to complete the 60-day study by the end of 2012.
About Targeted Medical Pharma, Inc.'s Medical Foods
Targeted Medical Pharma's medical foods are amino acid-based, FDA-regulated medications specially formulated to meet the body's increased nutritional requirements of certain disease states. They are a safe and effective option for treating pain syndromes, sleep and cognitive disorders, obesity, hypertension and peripheral neuropathy without harmful side effects. These medical foods are available by prescription only and must be administered under the ongoing supervision of a physician.
About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. is a specialty pharmaceutical company that developsand sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders. The company manufactures ten proprietary prescription only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. Based in Los Angeles, the company's proprietary pharmaceutical therapeutic systems are currently sold in the United States and Japan. Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.
Forward Looking Statement
This press release may contain forward-looking statements related to Targeted Medical Pharma's business strategy, outlook, objectives, plans, intentions or goals. The words "believe," "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Actual results could differ materially. Targeted Medical Pharma expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.
PondelWilkinson
Media Contacts:
George Medici gmedici@pondel.com
Ron Neal rneal@pondel.com
(310) 279-5980
or
Investor Contacts:
Roger Pondel Matt Sheldon
investors@tmedpharma.com
(310) 279-5975
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article Targeted Medical Pharma Introduces Medical Food PERCURA™ for Dietary Management of Peripheral Neuropathy originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
